Inconspicuous consumption: Disseminated tuberculosis following untreated latent infection

Journal of Paediatrics and Child Health

Volumn 40, Issue 4, 2004, Pages 227-229

  Blyth, C ^a   Waring, J ^a   Burgner, D ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ANAMNESIS; ARTICLE; ASPIRATION BIOPSY; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; DRUG TOLERABILITY; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION; LABORATORY TEST; LYMPH NODE BIOPSY; MILIARY TUBERCULOSIS; PEDIATRICS; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; THORAX RADIOGRAPHY; TREATMENT OUTCOME; TUBERCULIN TEST;

ANTIBIOTICS, ANTITUBERCULAR; CHILD, PRESCHOOL; FEMALE; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PHYSICIAN'S PRACTICE PATTERNS; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 2342650911     PISSN: 10344810     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1754.2004.00343.x     Document Type: Article

References (19)

1. World Health Organization. Global Tuberculosis Control: Surveillance, Planning, Financing. Geneva: WHO, 2002.
2. Costello AM, Rook G. Tuberculosis in children. Curr. Opin. Pediatr. 1995; 7: 6-12.
3. McSherry G, Connor E. Current epidemiology of tuberculosis. Pediatr. Ann. 1993; 22: 600-4.
4. Davies PD, Williams CS. Tuberculosis is increasing in England and Wales. Tubercle Lung Dis. 1993; 74: 350-1.
5. Miller M, Lin M, Spencer J et al. Tuberculosis notifications in Australia. CDI 2001; 26: 525-36.
6. Powell KE, Meador MP, Farer LS. Recent trends in tuberculosis in children. JAMA 1984; 251: 1289-92.
7. Haas DW. Mycobacterium tuberculosis. In: Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Diseases, 5th edn. New York: Churchil Livingstone, 2000; 2576-607.
8. Styblo K. Recent advances in epidemiological research in tuberculosis. Adv. Tuberc. Res. 1980; 20: 1-63.
9. Saiman L, San Gabriel P, Schulte J, Vargas MP, Kenyon T, Onorato I. Risk factors for latent tuberculosis infection among children in New York City. Pediatrics 2001; 107: 999-1003.
10. Voss LM. Management of tuberculosis in children. J. Paediatr. Child Health 2000; 36: 530-6.
11. Ormerod LP. Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis. Arch. Dis. Child 1998; 78: 169-71.
12. Curry FJ. Prophylactic effect of isoniazid in young tuberculin reactors. N. Engl. J. Med. 1967; 277: 562-7.
13. Smieja MJ, Marchetti CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database Syst. Rev. 2000; CD001363.
14. Stein MT, Liang D. Clinical hepatotoxicity of isoniazid in children. Pediatrics 1979; 64: 499-505.
15. Comstock GW, Hammes LM, Pio A. Isoniazid prophylaxis in Alaskan boarding schools. A comparison of two doses. Am. Rev. Respir. Dis. 1969; 100: 773-9.
16. O'Brien RJ, Long MW, Cross FS, Lyle MA, Snider DE Jr. Hepatotoxicity from isoniazid and rifampin among children treated for tuberculosis. Pediatrics 1983; 72: 491-9.
17. Khan K, Muennig P, Behta M, Zivin JG. Global drug-resistance patterns and the management of latent tuberculosis infection in immigrants to the United States. N. Engl. J. Med. 2002; 347: 1850-9.
18. National TB Advisory Committee. National Strategic Plan for TB Control in Australia Beyond 2000. Communicable Diseases Network Australia, 2002. Available from: http://www.cda.gov.au/ pubs/other/tb_plan.htm. Accessed July 2003.
19. MacIntyre CR, Plant AJ, Yung A, Streeton JA. Missed opportunities for prevention of tuberculosis in Victoria, Australia. Int. J. Tuberc. Lung Dis. 1997; 1: 135-41.